SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-05-002537
Filing Date
2005-05-24
Accepted
2005-05-24 16:09:07
Documents
2
Period of Report
2005-05-24
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_4944.htm 8-K 10918
2 EX-99.1 exhibit1.htm EX-99.1 6049
  Complete submission text file 0001299933-05-002537.txt   18418
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23736 | Film No.: 05854496
SIC: 2834 Pharmaceutical Preparations